Info
European insolvency law : reform and harmonization / / Gerard McCormack, Andrew Keay, and Sarah Brown
| European insolvency law : reform and harmonization / / Gerard McCormack, Andrew Keay, and Sarah Brown |
| Autore | McCormack G (Gerard) |
| Pubbl/distr/stampa | Cheltenham, : Edward Elgar Publishing, 2017 |
| Descrizione fisica | 1 online resource (xvi, 487 p.) |
| Disciplina | 346.24078 |
| Altri autori (Persone) |
KeayAndrew
BrownSarah |
| Soggetto topico |
Bankruptcy - European Union countries
financial solvency bankruptcy national law EU Member State comparative law |
| ISBN | 1-78643-331-1 |
| Classificazione | 40.04.12 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Directors' liability and disqualification -- 2. Insolvency practitioners (administrators, liquidators, supervisors, mediators etc.) -- 3. Ranking of claims and order of priorities -- 4. Avoidance and adjustment actions -- 5. Procedural issues relating to formal insolvency proceedings -- 6. Commission recommendation on a new approach to business failure and insolvency -- 7. Second chance for entrepreneurs -- 8. Consumer over-indebtedness |
| Record Nr. | UNINA-9910162919803321 |
McCormack G (Gerard)
|
||
| Cheltenham, : Edward Elgar Publishing, 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Images and human rights : local and global perspectives / / edited by Nancy Lipkin Stein and Alison Dundes Renteln
| Images and human rights : local and global perspectives / / edited by Nancy Lipkin Stein and Alison Dundes Renteln |
| Pubbl/distr/stampa | Cambridge Scholars Publishing |
| Disciplina | 341.48 |
| Soggetto topico |
Human rights
Human rights - 21st century Images, Photographic - Social aspects |
| ISBN | 1-4438-6269-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Images and human rights: Local and global perspectives / Nancy Lipkin Stein and Alison Dundes Renteln -- The human right to photograph / Michel Angela Martinez and Alison Dundes Renteln -- Human rights films and disability: Towards observational cinema as a practice of "shared human rights" / Anastasia Klupchak -- Perception of the visual: We see with our brains / Sarah Brown -- The nature of being: A sense of meaning virtue and other values of the Ovahimba / Rina Sherman -- "In God we trust": Islam, photographs, and imaginations of Bangladesh / Fabiene Gama -- One hundred years of suffering? "Humanitarian crisis photography" and self-representation in the Democratic Republic of the Congo / Aubrey P. Graham -- Visions of sex-trafficking: The filmic representation of suffering / Katherine Wahlberg -- An evolutionary process of capturing images of people experiencing homelessness / Dr. Andra Opalinski, Dr. Susan Dyess and Dr. Nancy Stein -- Memes, mashups, and the battle for the future of human culture / Tok Thompson -- Images of trans: Framing the way we see transgender people / Nancy Lipkin Stein. |
| Record Nr. | UNINA-9910792552803321 |
| Cambridge Scholars Publishing | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Perspectives on evaluating criminal justice and corrections [[electronic resource] /] / edited by Erica Bowen, Sarah Brown
| Perspectives on evaluating criminal justice and corrections [[electronic resource] /] / edited by Erica Bowen, Sarah Brown |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Bingley [England], : Emerald Insight, 2012 |
| Descrizione fisica | 1 online resource (275 p.) |
| Disciplina | 364 |
| Altri autori (Persone) |
BowenErica <1976->
BrownSarah |
| Collana | Advances in program evaluation |
| Soggetto topico |
Education - Evaluation
Organization & management of education Rehabilitation of offenders Crime & criminology Corrections - Evaluation Criminal justice, Administration of |
| ISBN |
1-280-99907-1
9786613770684 1-78052-645-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Using Theory in Criminal Justice Evaluation / Brad Astbury -- The Risk/Needs/Responsivity Model: The Crucial Features of General Responsivity / L.E. Marshall, W.L. Marshall -- Arguments about Methods in Criminal Justice Evaluation / David Smith -- Treatment of Sexual Offenders: Effective Elements and Appropriate Outcome Evaluations / W.L. Marshall, L.E. Marshall -- Resolving Ethical Issues in Randomised Controlled Trials / Robert F. Boruch, Joe S. Cecil, Herb Turner, Timothy Victor, Jordan M. Hyatt -- Critical Qualitative Theory: Opening up the Black Box of Criminal Justice Interventions / Matt Barnard -- Within-Treatment Change: Finding the Individual in Group Outcomes / Erica Bowen -- Propensity Score Analysis / Sarah Brown -- Developing Offender Engagement: Evaluating Probation Trust Pilots / Sue Rex, Elaine Ellis, Nigel Hosking, Wendy Hyett -- Offenders at the Heart of Evaluation / Barry Kushner, Saville Kushner -- From Text Books to Footpaths: Making Real-World Research Stick at the Coal Face / Ian Lambie, Julia Ioane. |
| Record Nr. | UNINA-9910672259503321 |
| Bingley [England], : Emerald Insight, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A practical guide to designing phase II trials in oncology / / [edited by] Sarah R. Brown, Walter M
| A practical guide to designing phase II trials in oncology / / [edited by] Sarah R. Brown, Walter M |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom : , : John Wiley & Sons, , 2014 |
| Descrizione fisica | 1 online resource (258 p.) |
| Disciplina | 616.99/4061 |
| Collana | Statistics in Practice |
| Soggetto topico | Antineoplastic agents |
| ISBN |
1-118-76363-7
1-118-76361-0 1-118-76362-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
A Practical Guide to Designing Phase II Trials in Oncology; Contents; Contributors; Foreword I; Foreword II; Preface; 1 Introduction; 1.1 The role of phase II trials in cancer; 1.2 The importance of appropriate phase II trial design; 1.3 Current use of phase II designs; 1.4 Identifying appropriate phase II trial designs; 1.5 Potential trial designs; 1.6 Using the guidance to design your trial; 2 Key points for consideration; 2.1 Stage 1 - Trial questions; 2.1.1 Therapeutic considerations; 2.1.2 Primary intention of trial; 2.1.3 Number of experimental treatment arms
2.1.4 Primary outcome of interest2.2 Stage 2 - Design components; 2.2.1 Outcome measure and distribution; 2.2.2 Randomisation; 2.2.3 Design category; 2.3 Stage 3 - Practicalities; 2.3.1 Practical considerations; 2.4 Summary; 3 Designs for single experimental therapies with a single arm; 3.1 One-stage designs; 3.1.1 Binary outcome measure; 3.1.2 Continuous outcome measure; 3.1.3 Multinomial outcome measure; 3.1.4 Time-to-event outcome measure; 3.1.5 Ratio of times to progression; 3.2 Two-stage designs; 3.2.1 Binary outcome measure; 3.2.2 Continuous outcome measure 3.2.3 Multinomial outcome measure3.2.4 Time-to-event outcome measure; 3.2.5 Ratio of times to progression; 3.3 Multi-stage designs; 3.3.1 Binary outcome measure; 3.3.2 Continuous outcome measure; 3.3.3 Multinomial outcome measure; 3.3.4 Time-to-event outcome measure; 3.3.5 Ratio of times to progression; 3.4 Continuous monitoring designs; 3.4.1 Binary outcome measure; 3.4.2 Continuous outcome measure; 3.4.3 Multinomial outcome measure; 3.4.4 Time-to-event outcome measure; 3.4.5 Ratio of times to progression; 3.5 Decision-theoretic designs; 3.5.1 Binary outcome measure 3.5.2 Continuous outcome measure3.5.3 Multinomial outcome measure; 3.5.4 Time-to-event outcome measure; 3.5.5 Ratio of times to progression; 3.6 Three-outcome designs; 3.6.1 Binary outcome measure; 3.6.2 Continuous outcome measure; 3.6.3 Multinomial outcome measure; 3.6.4 Time-to-event outcome measure; 3.6.5 Ratio of times to progression; 3.7 Phase II/III designs; 4 Designs for single experimental therapies including randomisation; 4.1 One-stage designs; 4.1.1 Binary outcome measure; 4.1.2 Continuous outcome measure; 4.1.3 Multinomial outcome measure; 4.1.4 Time-to-event outcome measure 4.1.5 Ratio of times to progression4.2 Two-stage designs; 4.2.1 Binary outcome measure; 4.2.2 Continuous outcome measure; 4.2.3 Multinomial outcome measure; 4.2.4 Time-to-event outcome measure; 4.2.5 Ratio of times to progression; 4.3 Multi-stage designs; 4.3.1 Binary outcome measure; 4.3.2 Continuous outcome measure; 4.3.3 Multinomial outcome measure; 4.3.4 Time-to-event outcome measure; 4.3.5 Ratio of times to progression; 4.4 Continuous monitoring designs; 4.4.1 Binary outcome measure; 4.4.2 Continuous outcome measure; 4.4.3 Multinomial outcome measure; 4.4.4 Time-to-event outcome measure 4.4.5 Ratio of times to progression |
| Record Nr. | UNINA-9910140271703321 |
| Chichester, West Sussex, United Kingdom : , : John Wiley & Sons, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A practical guide to designing phase II trials in oncology / / [edited by] Sarah R. Brown, Walter M
| A practical guide to designing phase II trials in oncology / / [edited by] Sarah R. Brown, Walter M |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom : , : John Wiley & Sons, , 2014 |
| Descrizione fisica | 1 online resource (258 p.) |
| Disciplina | 616.99/4061 |
| Collana | Statistics in Practice |
| Soggetto topico | Antineoplastic agents |
| ISBN |
1-118-76363-7
1-118-76361-0 1-118-76362-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
A Practical Guide to Designing Phase II Trials in Oncology; Contents; Contributors; Foreword I; Foreword II; Preface; 1 Introduction; 1.1 The role of phase II trials in cancer; 1.2 The importance of appropriate phase II trial design; 1.3 Current use of phase II designs; 1.4 Identifying appropriate phase II trial designs; 1.5 Potential trial designs; 1.6 Using the guidance to design your trial; 2 Key points for consideration; 2.1 Stage 1 - Trial questions; 2.1.1 Therapeutic considerations; 2.1.2 Primary intention of trial; 2.1.3 Number of experimental treatment arms
2.1.4 Primary outcome of interest2.2 Stage 2 - Design components; 2.2.1 Outcome measure and distribution; 2.2.2 Randomisation; 2.2.3 Design category; 2.3 Stage 3 - Practicalities; 2.3.1 Practical considerations; 2.4 Summary; 3 Designs for single experimental therapies with a single arm; 3.1 One-stage designs; 3.1.1 Binary outcome measure; 3.1.2 Continuous outcome measure; 3.1.3 Multinomial outcome measure; 3.1.4 Time-to-event outcome measure; 3.1.5 Ratio of times to progression; 3.2 Two-stage designs; 3.2.1 Binary outcome measure; 3.2.2 Continuous outcome measure 3.2.3 Multinomial outcome measure3.2.4 Time-to-event outcome measure; 3.2.5 Ratio of times to progression; 3.3 Multi-stage designs; 3.3.1 Binary outcome measure; 3.3.2 Continuous outcome measure; 3.3.3 Multinomial outcome measure; 3.3.4 Time-to-event outcome measure; 3.3.5 Ratio of times to progression; 3.4 Continuous monitoring designs; 3.4.1 Binary outcome measure; 3.4.2 Continuous outcome measure; 3.4.3 Multinomial outcome measure; 3.4.4 Time-to-event outcome measure; 3.4.5 Ratio of times to progression; 3.5 Decision-theoretic designs; 3.5.1 Binary outcome measure 3.5.2 Continuous outcome measure3.5.3 Multinomial outcome measure; 3.5.4 Time-to-event outcome measure; 3.5.5 Ratio of times to progression; 3.6 Three-outcome designs; 3.6.1 Binary outcome measure; 3.6.2 Continuous outcome measure; 3.6.3 Multinomial outcome measure; 3.6.4 Time-to-event outcome measure; 3.6.5 Ratio of times to progression; 3.7 Phase II/III designs; 4 Designs for single experimental therapies including randomisation; 4.1 One-stage designs; 4.1.1 Binary outcome measure; 4.1.2 Continuous outcome measure; 4.1.3 Multinomial outcome measure; 4.1.4 Time-to-event outcome measure 4.1.5 Ratio of times to progression4.2 Two-stage designs; 4.2.1 Binary outcome measure; 4.2.2 Continuous outcome measure; 4.2.3 Multinomial outcome measure; 4.2.4 Time-to-event outcome measure; 4.2.5 Ratio of times to progression; 4.3 Multi-stage designs; 4.3.1 Binary outcome measure; 4.3.2 Continuous outcome measure; 4.3.3 Multinomial outcome measure; 4.3.4 Time-to-event outcome measure; 4.3.5 Ratio of times to progression; 4.4 Continuous monitoring designs; 4.4.1 Binary outcome measure; 4.4.2 Continuous outcome measure; 4.4.3 Multinomial outcome measure; 4.4.4 Time-to-event outcome measure 4.4.5 Ratio of times to progression |
| Record Nr. | UNINA-9910821270803321 |
| Chichester, West Sussex, United Kingdom : , : John Wiley & Sons, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||